Vanda Pharma (NASDAQ:VNDA) Stock Quotes, Forecast and News Summary

Q: What sector and industry does Vanda Pharma (VNDA) operate in?

Vanda Pharma is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Vanda Pharma Stock (NASDAQ: VNDA) stock price, news, charts, stock research, profile.

Open	$4.91
Close	-
Volume / Avg.	135.33K / 609.48K
Day Range	$4.83 - $4.93
52 Wk Range	3.44 - 6.75
Market Cap	$285.71M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	49
Short Interest	7.76%
Days to Cover	9.28

Recent News

Over 200% Stock Upside - Vanda Pharmaceuticals Undervalued With Robust Portfolio And Pipeline: Analyst

HC Wainwright initiates Buy on Vanda Pharmaceuticals with an $18 price target, citing undervaluation, a strong product portfolio, and growth in neurology.

Vandana Singh

VNDA Stock Down as FDA Rejects NDA for Tradipitant in Gastroparesis

Vanda Pharmaceuticals Inc. (NASDAQ: VNDA) announced that the FDA issued a complete response letter to its new drug application (NDA) seeking approval for its pipeline candidate, tradipitant for the treatment of symptoms in gastroparesis.

Zacks

FDA Strikes Off Vanda Pharmaceuticals' Tradipitant For Stomach Paralysis, Asks For Additional Studies

The FDA rejected Vanda Pharmaceuticals' new drug application for tradipitant to treat gastroparesis, citing the need for more studies despite delays in its review process. Vanda argues the drug meets efficacy standards and plans to continue pursuing approval.

Vandana Singh

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

Jul

Aug

Oct

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

3.8

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Open	$4.91
Close	-
Volume / Avg.	135.33K / 609.48K
Day Range	$4.83 - $4.93
52 Wk Range	3.44 - 6.75
Market Cap	$285.71M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	49
Short Interest	7.76%
Days to Cover	9.28

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Vanda Pharma (VNDA) stock?

You can purchase shares of Vanda Pharma (NASDAQ:VNDA) through any online brokerage.

View our list of the best stock brokerages

Who are Vanda Pharma (VNDA) competitors?

Other companies in Vanda Pharma’s space includes: Precigen (NASDAQ:PGEN), Voyager Therapeutics (NASDAQ:VYGR), Sage Therapeutics (NASDAQ:SAGE), Fate Therapeutics (NASDAQ:FATE) and Tevogen Bio Holdings (NASDAQ:TVGN).

What is the forecast, or price target, for Vanda Pharma (VNDA) stock?

Vanda Pharma has a consensus price target of $14.33.

What is the current price for Vanda Pharma (VNDA)?

The stock price for Vanda Pharma (NASDAQ: VNDA) is $4.9 last updated November 21, 2024 at 12:21 PM EST.

Does Vanda Pharma (VNDA) pay a dividend?

There are no upcoming dividends for Vanda Pharma.

When is Vanda Pharma (NASDAQ:VNDA) reporting earnings?

Vanda Pharma’s Q4 earnings are confirmed for Wednesday, February 5, 2025.

Is Vanda Pharma (VNDA) going to split?

There is no upcoming split for Vanda Pharma.

What sector and industry does Vanda Pharma (VNDA) operate in?

Vanda Pharma is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Comments

Vanda Pharma

Vanda Pharma (VNDA) Forecast